Oxford Asset Management’s Zymeworks ZYME Stock Holding History

Oxford Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,812	Closed	-$696K	–	670
2026 Q1	$696K	Buy	+27,812	New	+$658K	0.28%	105
2025 Q4	–	Sell	-36,359	Closed	-$621K	–	778
2025 Q3	$621K	Buy	+36,359	New	+$520K	0.2%	149
2020 Q1	–	Sell	-29,311	Closed	-$1.33M	–	1355
2019 Q4	$1.33M	Sell	29,311 -39,826	-58%	-$1.45M	0.04%	675
2019 Q3	$1.72M	Sell	69,137 -47,616	-41%	-$1.19M	0.04%	634
2019 Q2	$2.57M	Buy	+116,753	New	+$2.14M	0.06%	532
2019 Q1	–	Sell	-28,402	Closed	-$417K	–	2035
2018 Q4	$417K	Buy	+28,402	New	+$373K	0.01%	1267
2017 Q3	–	Sell	-18,467	Closed	-$154K	–	1739
2017 Q2	$154K	Buy	+18,467	New	+$207K	﹤0.01%	1388

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Oxford Asset Management's ZYME Position: Q2 2026 in Review

Oxford Asset Management sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 27,812 shares — an estimated $696K sold.

Oxford Asset Management first reported a position in ZYME in Q2 2017 and held it in 7 quarters. The position peaked at $2.57M in Q2 2019. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Oxford Asset Management reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 27,812 Zymeworks shares in Q2 2026, an estimated $696K.
Oxford Asset Management first reported a position in Zymeworks in Q2 2017 and held it in 7 quarters.
Oxford Asset Management's Zymeworks position peaked at $2.57M in Q2 2019.
203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.